Crossmark

Diagnostic performance of contrast-enhanced ultrasonography for predicting therapeutic response to radiofrequency ablation in patients with hepatocellular carcinoma: a meta-analysis

Crossref DOI link: https://doi.org/10.1007/s12672-025-03008-x

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dong, Ji

Hu, Xin

Li, Lin

Jing, Fei-Yan

Chen, Jin-Jin

Chen, Jun
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 3 December 2024

Accepted: 17 June 2025

First Online: 1 July 2025

Declarations

:

: This study does not contain any participates, and ethic approval is not applicable. This study does not contain any participates, and patient consent is not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below